Clinical Trial Update: Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating on the use of the PET tracer [18F]-FES to image estrogen receptor–positive breast cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• 18F-FES (18F-fluoroestradiol)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Breast Cancer, Brain Metastases | Phase 4 | Status: RECRUITING